Under Construction

This site is still under construction. Please excuse the mess and inconsistencies. All will be fixed eventually. It is best to not link to individual pages yet, as their URLs are very likely to change. Once this message disappears, it will be safe to use specific links. In the meantime, please just link to the site's home page, which can always be found by clicking on the image in the title area at the top of any page.

15 July 2006

HERBS: MILK THISTLE

MILK THISTLE

TIP: when searching for studies regarding "silybin phytosome", as opposed to silymarin, try using its other term "IdB 1016".

Silybin Phytosome (Index of clinical studies)

http://www.liversupport.com/studiesindex.htm
Silybin Phytomsome is the active ingredient in "Maximum Milk Thistle"
Studies you can link to from this page include:
  • Effect of Silybin Phytosome on chronic active hepatitis (Ref20C15)
  • Therapeutic effect of Silybin Phytosome... (Ref21C13)
  • Direct comparison of Silybin Phytosome to standardized milk thistle extract...(Ref8P22)
  • Useful dosages of Silybin Phytosome (Ref18C14)
  • Considerably greater bioavailability of silybin as a component of Silybin Phytosome (c10)
  • Increased oral bioavailability of Silybin Phytosome in humans (c3medline)
  • Effect of Silybin Phytosome on cirrhotic patients (Ref9c8)
  • Liver damage control properties of Silybin Phytosome (Ref12P19)
  • Free radical scavenging properties of Silybin Phytosome (Ref13P6)
  • Effect of silymarin on lipid peroxidation (Ref14P13)
  • Silybin Phytosome counteracts hepatotoxic effects (Ref15P16)
  • Antioxidant activity of Silybin Phytosome against alcohol (Ref16P23)
  • Tolerability and effectiveness of Silybin Phytosome (Ref19C6)
  • Liver protection potential of Silybin Phytosome (c6medline)
  • Comparative bioavailability of Silybin Phytosome vs. silybin (Ref7P12)
  • Liver protective activity...Silybin Phytosome more effective than its constituents alone (Ref11P1)
Clinical Trials.gov - "IdB 1016 Treatment for Hepatitis C Disease"
ClinicalTrials.gov Identifier: NCT00055445
University of Washington Medical Center in Seattle, WA
Study began Nov. 2003 and was completed Apr. 2006

No comments: